7 unchanged sentences
Specimen Common Stock Certificate
−Removed: Consulting Agreement effective as of October 1, 2022, by and between CytomX Therapeutics, Inc.
−Removed: and Carlos Campoy .
−Removed: Consulting Agreement effective as of September 13, 2022, by and between CytomX Therapeutics, Inc.
−Removed: Peterson, M.D.
−Removed: Separation Agreement effective as of September 30, 2022, by and between CytomX Therapeutics, Inc.
−Removed: and Carlos Campoy.
−Removed: Separation Agreement effective as of September 12, 2022, by and between CytomX Therapeutics, Inc.
−Removed: Peterson, M.D.
−Removed: Separation Agreement effective as of September 30, 2022, by and between CytomX Therapeutics, Inc.
−Removed: and Alison Hannah, M.D.
−Removed: Amendment No 3 to Collaboration and License Agreement, dated May 23, 2014, by and between the Company and Bristol Myers Squibb Company, effective as of October 11, 2022.
−Removed: Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
−Removed: Certification of Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).
+Added: Sublease Agreement dated as of March 24, 2023, by and between CytomX Therapeutics, Inc and Atomic AI, Inc.
+Added: Certification of Chief Executive Principal required by Rule 13a-14(a) or Rule 15d-14(a).
+Added: Certification of Chief Financial Principal required by Rule 13a-14(a) or Rule 15d-14(a).
Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.
−Removed: Certification of Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.
+Added: Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C.
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
5 unchanged sentences
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
−Removed: Certain confidential portions of this exhibit have been omitted from this exhibit.
−Removed: # Indicates management contract or compensatory plan.
* The certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the SEC and are not to be incorporated by reference into any filing of CytomX Therapeutics, Inc.
2 unchanged sentences
CytomX Therapeutics, Inc.
−Removed: November 8, 2022
Chief Executive Officer and Chairman
(Principal Executive Officer)
−Removed: November 8, 2022
/s/ Christopher W.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.